Similar articles for PMID: 32014901

Year	Number of Results
1990	1
1992	2
1995	1
1996	2
1998	2
1999	2
2000	1
2001	1
2002	1
2003	2
2006	2
2007	2
2008	1
2010	2
2011	2
2012	1
2013	3
2014	5
2015	12
2016	10
2017	11
2018	10
2019	5
2020	3
2022	1
2023	1
2024	0

1

C-myc Contributes to Malignancy of Lung Cancer: A Potential Anticancer Drug Target.

Chanvorachote P, Sriratanasak N, Nonpanya N. Chanvorachote P, et al. Anticancer Res. 2020 Feb;40(2):609-618. doi: 10.21873/anticanres.13990. Anticancer Res. 2020. PMID: 32014901 Review.

2

MYC, MYCL, and MYCN as therapeutic targets in lung cancer.

Massó-Vallés D, Beaulieu ME, Soucek L. Massó-Vallés D, et al. Expert Opin Ther Targets. 2020 Feb;24(2):101-114. doi: 10.1080/14728222.2020.1723548. Epub 2020 Feb 13. Expert Opin Ther Targets. 2020. PMID: 32003251 Review.

3

Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas.

Ciribilli Y, Singh P, Spanel R, Inga A, Borlak J. Ciribilli Y, et al. Oncotarget. 2015 Oct 13;6(31):31569-92. doi: 10.18632/oncotarget.5035. Oncotarget. 2015. PMID: 26427040 Free PMC article.

4

Emerging roles of Myc in stem cell biology and novel tumor therapies.

Yoshida GJ. Yoshida GJ. J Exp Clin Cancer Res. 2018 Jul 27;37(1):173. doi: 10.1186/s13046-018-0835-y. J Exp Clin Cancer Res. 2018. PMID: 30053872 Free PMC article. Review.

5

MicroRNA-451 induces epithelial-mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc.

Chen D, Huang J, Zhang K, Pan B, Chen J, De W, Wang R, Chen L. Chen D, et al. Eur J Cancer. 2014 Nov;50(17):3050-67. doi: 10.1016/j.ejca.2014.09.008. Epub 2014 Oct 10. Eur J Cancer. 2014. PMID: 25310895

6

MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.

Lin TC, Lin PL, Cheng YW, Wu TC, Chou MC, Chen CY, Lee H. Lin TC, et al. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1532-9. doi: 10.1245/s10434-015-4595-z. Epub 2015 May 20. Ann Surg Oncol. 2015. PMID: 25990966

7

N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc.

Wang Y, Zhou Y, Tao F, Chai S, Xu X, Yang Y, Yang Y, Xu H, Wang K. Wang Y, et al. Cancer Lett. 2017 Aug 10;401:53-62. doi: 10.1016/j.canlet.2017.04.031. Epub 2017 Apr 27. Cancer Lett. 2017. PMID: 28456659

8

Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas.

Bouillez A, Rajabi H, Pitroda S, Jin C, Alam M, Kharbanda A, Tagde A, Wong KK, Kufe D. Bouillez A, et al. Cancer Res. 2016 Mar 15;76(6):1538-48. doi: 10.1158/0008-5472.CAN-15-1804. Epub 2016 Feb 1. Cancer Res. 2016. PMID: 26833129 Free PMC article.

9

Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.

Izumi D, Ishimoto T, Miyake K, Eto T, Arima K, Kiyozumi Y, Uchihara T, Kurashige J, Iwatsuki M, Baba Y, Sakamoto Y, Miyamoto Y, Yoshida N, Watanabe M, Goel A, Tan P, Baba H. Izumi D, et al. Stem Cells. 2017 Sep;35(9):2027-2036. doi: 10.1002/stem.2668. Epub 2017 Jul 31. Stem Cells. 2017. PMID: 28699179

10

MYC-induced epigenetic activation of GATA4 in lung adenocarcinoma.

Castro IC, Breiling A, Luetkenhaus K, Ceteci F, Hausmann S, Kress S, Lyko F, Rudel T, Rapp UR. Castro IC, et al. Mol Cancer Res. 2013 Feb;11(2):161-72. doi: 10.1158/1541-7786.MCR-12-0414-T. Epub 2012 Dec 13. Mol Cancer Res. 2013. PMID: 23239811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

79 results

Results by year